[1]
M. D. KARAKOÇ and D. İlke ÇIKMAN, “Pharmacoeconomic Evaluation Of Trastuzumab Emtansine And Pertuzumab Treatments In Metastatic Breast Cancer Patients”, GNJ, vol. 5, no. 8, pp. 105–112, Jul. 2022.